![]() |
Vaccines |
Free Subscription
1 BMC Pediatr |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Vaccination dropout and associated factors among children in Ethiopia: a
systematic review and meta-analysis (2014-2024).
BMC Pediatr. 2025;25:426.
PubMed
Abstract available
US no longer recommends covid-19 vaccinations for pregnant women or children.
BMJ. 2025;389:r1104.
PubMed
Corrigendum to "Underlying health biases in previously-infected SARS-CoV-2
vaccination recipients: A cohort study" [J Infect 90 (2025) 106497].
J Infect. 2025;91:106522.
PubMed
Immune impacts of infant whole-cell and acellular pertussis vaccination on
co-administered vaccines.
J Infect. 2025 May 23:106515. doi: 10.1016/j.jinf.2025.106515.
PubMed
Abstract available
Recurrent invasive pneumococcal disease in children: A retrospective cohort
study, England, 2006/07-2017/18.
J Infect. 2025;90:106490.
PubMed
Abstract available
Logistics of the malaria vaccine roll-out in Nigeria.
Lancet. 2025;405:1815.
PubMed
Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing
Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months
in Argentina: Multicenter Case-control Study.
Pediatr Infect Dis J. 2025 May 28. doi: 10.1097/INF.0000000000004878.
PubMed
Abstract available
Bring Back Vaccinia!
Pediatr Infect Dis J. 2025 May 21. doi: 10.1097/INF.0000000000004863.
PubMed
Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination,
and international travel across Belgian provinces in 2021.
PLoS One. 2025;20:e0322017.
PubMed
Abstract available
Mortality in severe serious adverse events following heterologous and homologous
prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study.
PLoS One. 2025;20:e0323736.
PubMed
Abstract available
Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district
(Odisha), India: A prospective study protocol.
PLoS One. 2025;20:e0317621.
PubMed
Abstract available
Protection induced in pigs previously infected by the non-virulent strain 1330 of
Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin
suicin.
PLoS One. 2025;20:e0323370.
PubMed
Abstract available
COVID-19 vaccination and utility of booster dose: A community-based
cross-sectional study.
Vaccine. 2025;60:127325.
PubMed
Abstract available
National trends and disparities in herpes zoster vaccination coverage among U.S.
older adults with cancer, 2008-2023.
Vaccine. 2025;60:127326.
PubMed
Abstract available
Risk of Guillain-Barre syndrome after COVID-19 vaccination or SARS-CoV-2
infection: A multinational self-controlled case series study.
Vaccine. 2025;60:127291.
PubMed
Abstract available
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative
case-control study.
Vaccine. 2025;59:127295.
PubMed
Abstract available
A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates
potent neutralization and protective abilities against flaviviruses without risk
of disease enhancement.
Vaccine. 2025;57:127219.
PubMed
Abstract available
Serotype dynamics of Streptococcus pneumoniae in some countries in Eastern Europe
and Central Asia.
Vaccine. 2025;57:127213.
PubMed
Abstract available
Measles-mumps-rubella booster and post-COVID-19 immunity: A retrospective cohort
study.
Vaccine. 2025;57:127232.
PubMed
Abstract available
Assessing measles immunity among healthcare workers, a systematic review of
peer-reviewed literature (2013-2023). Where do we go from here?
Vaccine. 2025;57:127214.
PubMed
Abstract available
The illness of empress Maria Theresa as a trigger for the adoption of variolation
in Austria (1768).
Vaccine. 2025;58:127253.
PubMed
Abstract available
Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by
different COVID-19 vaccine types: Insights into protection against wildtype,
Delta and JN.1 omicron strains.
Vaccine. 2025;59:127270.
PubMed
Abstract available
COVID-19 pandemic: A multidimensional analysis and the strategic role played by
developing countries vaccine manufacturers.
Vaccine. 2025;59:127271.
PubMed
Abstract available
Challenges in coverage of future hepatitis C vaccines: Review and potential
solutions.
Vaccine. 2025;59:127256.
PubMed
Abstract available
Quality and usability of home-based record photos to assess vaccine coverage: A
case study from the 2022 Democratic Republic of the Congo Vaccine Coverage
Survey.
Vaccine. 2025;59:127248.
PubMed
Abstract available
Safe and efficacious inactivated immersion vaccine against KG+ phenotype of
emerging bacterial pathogen Lactococcus garvieae for early developmental stage of
rainbow trout (Oncorhynchus mykiss) in India.
Vaccine. 2025;59:127266.
PubMed
Abstract available
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with
influenza or SARS-CoV-2 vaccines in adults: A systematic review and
Meta-analysis.
Vaccine. 2025;59:127293.
PubMed
Abstract available
"The only vaccine that we really question is the new vaccine": A qualitative
exploration of the social and behavioural drivers of human papillomavirus (HPV)
vaccination in Tonga.
Vaccine. 2025;59:127280.
PubMed
Abstract available
Live attenuated hfq-deleted Acinetobacter baumannii vaccine provides protection
against systemic infection.
Vaccine. 2025;59:127298.
PubMed
Abstract available
Breakthrough herpes zoster risk after recombinant zoster vaccination.
Vaccine. 2025 May 23:127294. doi: 10.1016/j.vaccine.2025.127294.
PubMed
Factors associated with primary care providers' recommendation of HPV vaccination
for adolescent males in China: A mixed-methods study.
Vaccine. 2025;59:127299.
PubMed
Abstract available
Understanding the shift in COVID-19 vaccine hesitancy and its associated factors
for primary and booster doses among university students: A cross-sectional study.
Vaccine. 2025;59:127296.
PubMed
Abstract available
Influenza vaccination during early pregnancy and risk of major birth defects, US
Birth Defects Study To Evaluate Pregnancy exposureS, 2014-2019.
Vaccine. 2025;59:127297.
PubMed
Abstract available
Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d/PRRSV
co-challenge model.
Vaccine. 2025;60:127303.
PubMed
Abstract available
Nationwide rollout of HPV vaccination in Nepal: Early key insights.
Vaccine. 2025;60:127312.
PubMed
PcrV in an intranasal adjuvanted tobacco mosaic virus conjugate vaccine mediates
protection from Pseudomonas aeruginosa via an early Th1/Th17 skewed localized and
systemic immune response.
Vaccine. 2025;60:127306.
PubMed
Abstract available
Limited durability of protection conferred by XBB.1.5 vaccines against
omicron-associated severe outcomes among community-dwelling adults, Ontario,
Canada.
Vaccine. 2025;60:127300.
PubMed
Abstract available
Development and characterization of MRC-5 and Vero cell-adapted enterovirus D68
strains for vaccine production.
Vaccine. 2025;60:127314.
PubMed
Abstract available
Prediction of subnational-level vaccination coverage estimates using routine
surveillance data and survey data.
Vaccine. 2025;60:127277.
PubMed
Abstract available
Altered germinal center responses in mice vaccinated with highly pathogenic avian
influenza A(H5N1) virus.
Vaccine. 2025;60:127311.
PubMed
Abstract available
Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps.
Vaccine. 2025;60:127309.
PubMed
Abstract available
A phase I, randomized, placebo-controlled, double-blind, ascending-dose and
single-center study to evaluate immunogenicity and safety of a live attenuated
tetravalent dengue vaccine (KD-382) in Flavivirus antibody-naive healthy adults.
Vaccine. 2025;60:127313.
PubMed
Abstract available
The guinea pig as a relevant preclinical model in the rat race for a vaccine
against congenital cytomegalovirus infection.
Virology. 2025;610:110560.
PubMed
Abstract available
Thank you for your interest in scientific medicine.